The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackrock I&g Regulatory News (BRIG)

Share Price Information for Blackrock I&g (BRIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 188.50
Bid: 188.00
Ask: 189.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.532%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 188.50
BRIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

21 Aug 2019 12:27

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

PR Newswire

London, August 21

BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC (LEI:5493003YBY59H9EJLJ16)
All information is at 31 July 2019 and unaudited.
Performance at month end with net income reinvested

One MonthThree MonthsOne YearThree YearsFive YearsSince 1 April 2012
Sterling
Share price 2.6% 2.1% 0.6%21.6%41.5%95.3%
Net asset value 1.8% 2.3% -0.5%22.7%43.3%84.1%
FTSE All-Share Total Return 2.0% 2.6% 1.3%27.0%38.9%80.0%
Source: BlackRock

BlackRock took over the investment management of the Company with effect from 1 April 2012.

At month end
Sterling:
Net asset value - capital only:203.24p
Net asset value - cum income*:205.85p
Share price:199.00p
Total assets (including income):£51.4m
Discount to cum-income NAV:3.3%
Gearing:2.2%
Net yield**:3.5%
Ordinary shares in issue***:23,017,476
Gearing range (as a % of net assets)0-20%
Ongoing charges****:1.1%

* includes net revenue of 2.61 pence per share
** The Company’s yield based on dividends announced in the last 12 months as at the date of the release of this announcement is 3.5% and includes the 2018 final dividend of 4.40p per share declared on 20 December 2018 and paid to shareholders on 19 March 2019 and the 2019 interim dividend of 2.60p per share declared on 25 June 2019 and due to be paid to shareholders on 2 September 2019.
*** excludes 9,916,456 shares held in treasury
**** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 31 October 2018.

Sector AnalysisTotal assets (%)
Oil & Gas Producers10.6
Pharmaceuticals & Biotechnology9.0
Media7.8
Life Insurance7.4
Financial Services6.9
Support Services6.6
Banks6.2
Food Producers5.2
Household Goods & Home Construction5.2
Tobacco4.4
Mining3.6
Food & Drug Retailers3.4
Travel & Leisure3.3
Gas, Water & Multiutilities2.8
Industrial Engineering2.4
Health Care Equipment & Services2.0
Mobile Telecommunications2.0
Nonlife Insurance2.0
Electronic & Electrical Equipment1.2
Construction & Materials0.9
Chemicals0.6
General Retailers0.5
Beverages0.3
Net Current Assets5.7
------
Total100.0
======
Ten Largest Equity Investments
CompanyTotal assets (%)
Royal Dutch Shell 'B'7.0
AstraZeneca4.8
RELX4.2
GlaxoSmithKline4.2
Prudential4.1
BP Group3.7
British American Tobacco3.6
BHP3.6
Tesco3.4
John Laing Group3.0

Commenting on the markets, Adam Avigdori and David Goldman representing the Investment Manager noted:
The UK market rose for a second consecutive month in July, returning 2.0% and bringing the calendar year to date returns for the UK Equity market to 15.0%. As expected the Federal Reserve cut US interest rates by 25bps, the first cut since 2008 in its July meeting. The immediate response was a strengthening of the US dollar and the US yield curve flattening, however markets had already been pricing in the shift in policy. Domestic momentum in the US remains relatively robust, however ongoing trade disputes continue to pose a risk to the US and the global growth outlook. Eurozone growth decelerated during Q2, in line with market expectations, which had been gradually reduced in response to softness in the economic data, and the European Central Bank kept interest rates on hold, however it signalled its intention to introduce a comprehensive easing package in upcoming meetings. Unsurprisingly, Boris Johnson was elected as the new UK Prime Minister by a clear majority, however the result does not reflect strong support for his Brexit agenda among the Conservative Party. He has now assembled his “pro-Brexit” Cabinet and pledged to leave the European Union on October 31 — with or without a deal. Sterling fell sharply as markets became increasingly worried over the prospect of a no-deal Brexit. With the slim majority in Parliament, there are a wide range of potential outcomes and uncertainty over Brexit remains high. Larger companies in the UK benefitted from the falling pound during the month and defensive sectors including Pharmaceuticals and Telecoms continued to outperform.
Over the quarter the BlackRock Income and Growth Investment Trust plc delivered a return of 1.8%, underperforming the FTSE All-Share which delivered a return of 2.0%.
British wealth manager St. James’s Place detracted after reporting that weaker client sentiment had weighed on inflows of new money in the first half of the year while costs rose, leading it to miss forecasts for operating profit. Premier Asset Management was another wealth manager featuring as a detractor after reporting outflows in its latest trading update, citing challenging conditions for the investment industry. The third biggest detractor was Bodycote, which as a global cyclical is sensitive to market concerns around the outlook for global growth. Bodycote also delivered results which we thought were very reassuring in light of the news flow from sector peers, and where its highest margin areas delivered. This remains a differentiated and well capitalised industrial, with a Management team we rate highly.
During the month we initiated positions in National Grid and Fuller Smith and Turner. We also added to positions in Vodafone and Weir. We have sold United Utilities and reduced exposure to RELX, AB Foods, Reckitt, Unilever, Bodycote and Hiscox.
We continue to see a period of sustained growth. Importantly, we expect nominal growth to remain modest as we see structural pressures from demographics, corporate underinvestment and new technology continuing to act as a drag on inflation. The dovish tilt from central banks is clearly supportive for markets, however from time to time we expect markets to worry about a shift to a more hawkish stance. With heightened political uncertainty and investor nervousness, we expect volatility to return to markets. This provides us, as active managers of a concentrated portfolio, with a great opportunity to identify high-quality cash generative businesses, with robust balance sheets, that can weather various market cycles and help to deliver long term capital and income growth for our clients.
We continue to like cash generative consumer staple companies, especially those exposed to the emerging market consumer given the prevalent demographic trends in certain markets. These companies often generate substantial cash flow which allows them to invest in innovation, marketing and distribution to ensure the longevity of their brands while also paying attractive and growing dividends to shareholders. We have also sought exposure to infrastructure spend whilst at the same time we are watching for signs of overheating in the US and monitoring economic growth in China. We also note that inflationary pressures are starting to build and therefore we seek those companies with sufficient pricing power and efficiency potential to withstand rising costs. As the recent past has demonstrated, it is crucial to be selective and to focus on those companies that are strong operators, that provide a differentiated service or product and that boast a strong balance sheet.
21 August 2019
Date   Source Headline
3rd May 202412:13 pmPRNNet Asset Value(s)
2nd May 202412:10 pmPRNNet Asset Value(s)
2nd May 20247:00 amPRNTotal Voting Rights
1st May 202412:10 pmPRNNet Asset Value(s)
1st May 20247:00 amPRNTotal Voting Rights
30th Apr 20244:04 pmPRNTransaction in Own Shares
30th Apr 202412:07 pmPRNNet Asset Value(s)
29th Apr 20245:02 pmPRNTransaction in Own Shares
29th Apr 202412:25 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 202411:45 amPRNNet Asset Value(s)
26th Apr 20247:00 amPRNTotal Voting Rights
25th Apr 20245:30 pmPRNTransaction in Own Shares
25th Apr 202412:14 pmPRNNet Asset Value(s)
24th Apr 20243:59 pmPRNTransaction in Own Shares
24th Apr 202412:15 pmPRNNet Asset Value(s)
23rd Apr 20244:44 pmPRNPortfolio Update
23rd Apr 202412:13 pmPRNNet Asset Value(s)
22nd Apr 202411:54 amPRNNet Asset Value(s)
19th Apr 202412:06 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 202412:16 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20246:03 pmPRNTransaction in Own Shares
17th Apr 202412:13 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:49 pmPRNTransaction in Own Shares
16th Apr 202412:02 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:10 pmPRNTransaction in Own Shares
15th Apr 202411:37 amPRNNet Asset Value(s)
15th Apr 20247:00 amPRNTotal Voting Rights
12th Apr 20244:32 pmPRNTransaction in Own Shares
12th Apr 202412:14 pmPRNNet Asset Value(s)
12th Apr 20247:00 amPRNTotal Voting Rights
11th Apr 20243:57 pmPRNTransaction in Own Shares
11th Apr 202412:11 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 20245:18 pmPRNTransaction in Own Shares
10th Apr 202412:06 pmPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20243:35 pmPRNTransaction in Own Shares
9th Apr 202411:45 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:15 pmPRNTransaction in Own Shares
8th Apr 202411:59 amPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20245:44 pmPRNTransaction in Own Shares
5th Apr 202412:15 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.